I don't think they go into that. I was told it is Bristol Meyers that refuses to work with Gilead. How do we find out the truth?
Oh, just as an aside. I just went through their 7977 and Riba treatment with very very little side effects. If you had gone through their treatment you might feel warm and fuzzy toward Gilead, believe me cause for type 2 and 3 it is a possible miracle, or at least close to one.
http://www.thestreet.com/story/11503957/1/grading-hep-c-stocks-exiting-easl-confab.html
Haven't read it yet, but I wonder does the article give any idea how much delay has been imposed on bringing the cure to market by Gliead's refusal to work with a competitor? Gliead's desire to monopolize the market means that hundreds of thousands of HCV sufferers won't have access to an interferon free cure for much longer than necessary. Now THAT shameful truth brings tears to my eyes.
A pan-genotypic cure has already been discovered, received fast track status and is ready to start phase 3 testing: GS-7977 with BMS-790052.
To be fair, I will read that article. It would be nice to be pleasantly surprised. Frankly I am expecting spin.
Don't want to sound negative but I'll believe it when I see it, They just had a promising drug that was suppose to be like this but it had to be discontinued because of heart problems!, I was devastated!, Don't need another let down!
I don't understand anyone saying it's put the cure back ten years! Gilead will be filing for FDA approval next year for 7977+riba for geno's 2 and 3 and look to hopefully follow that up in 2014 for geno 1's with 7977+5885.
What does one mean that they'll stop research? When you have the cure, you have the cure! Gilead have never stopped research with HIV. In fact they're the leading pharma in that department and I would say that the world should be very happy about that. Personally, I'm feeling very good about what they have to offer.